Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 66 articles:
HTML format
Text format



Single Articles


    January 2017
  1. VICTORA CG, Castro MC, Franca GV, Schuler-Faccini L, et al
    Zika rash and increased risk of congenital brain abnormalities - Authors' reply.
    Lancet. 2017;389:152.
    PubMed     Text format    


  2. GERARDIN P, Cao-Lormeau VM, Musso D, Despres P, et al
    Zika rash and increased risk of congenital brain abnormalities.
    Lancet. 2017;389:151-152.
    PubMed     Text format    


  3. THE LANCET
    Trastuzumab emtansine and cost-based decision making.
    Lancet. 2017;389:2.
    PubMed     Text format    


    December 2016
  4. WARREN RB, Mrowietz U, von Kiedrowski R, Niesmann J, et al
    An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2016 Dec 21. pii: S0140-6736(16)32127.
    PubMed     Text format     Abstract available


  5. GLADMAN DD
    Should methotrexate remain the first-line drug for psoriasis?
    Lancet. 2016 Dec 21. pii: S0140-6736(16)32574.
    PubMed     Text format    


    October 2016
  6. ZINK A, Bohner A, Schuch A, Biedermann T, et al
    Systemic mastocytosis with generalised skin involvement.
    Lancet. 2016 Oct 13. pii: S0140-6736(16)31710.
    PubMed     Text format    


  7. FINNERTY CC, Jeschke MG, Branski LK, Barret JP, et al
    Hypertrophic scarring: the greatest unmet challenge after burn injury.
    Lancet. 2016;388:1427-1436.
    PubMed     Text format     Abstract available


    September 2016
  8. THE LANCET
    Balancing the benefits and risks of choice.
    Lancet. 2016;388:1129.
    PubMed     Text format    


    August 2016
  9. DE LAVAL F, Matheus S, Maquart M, Yvrard E, et al
    Prospective Zika virus disease cohort: systematic screening.
    Lancet. 2016;388:868.
    PubMed     Text format    


    July 2016
  10. NATHWANI AC, Down JF, Goldstone J, Yassin J, et al
    Polonium-210 poisoning: a first-hand account.
    Lancet. 2016 Jul 22. pii: S0140-6736(16)00144.
    PubMed     Text format     Abstract available


  11. MATONO T, Kato Y, Yotsu R, Ohmagari N, et al
    Duplicate publication.
    Lancet. 2016;388:238.
    PubMed     Text format    


  12. STAHEL PF
    The inherent dangers of high-dose steroids for acute inflammatory conditions.
    Lancet. 2016;388:102.
    PubMed     Text format    


  13. LYNCH RW, Soane T, Gibson R, Pal S, et al
    Bilateral lower limb weakness in acute severe ulcerative colitis.
    Lancet. 2016;388:101-2.
    PubMed     Text format    


    June 2016
  14. FRANCA GV, Schuler-Faccini L, Oliveira WK, Henriques CM, et al
    Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30902.
    PubMed     Text format     Abstract available


  15. RUPERTO N, Pistorio A, Ravelli A, Angioloni S, et al
    The PRINTO juvenile dermatomyositis trial - Authors' reply.
    Lancet. 2016;387:2601.
    PubMed     Text format    


  16. DALE A, Milosevic I, Goldacre B
    The PRINTO juvenile dermatomyositis trial.
    Lancet. 2016;387:2600-1.
    PubMed     Text format    


  17. KHANNA D, Denton CP, Jahreis A, van Laar JM, et al
    Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.
    Lancet. 2016;387:2630-40.
    PubMed     Text format     Abstract available


  18. DISTLER O, Distler JH
    Tocilizumab for systemic sclerosis: implications for future trials.
    Lancet. 2016;387:2580-1.
    PubMed     Text format    


  19. OHUCHI N, Suzuki A, Yamamoto S, Kuriyama S, et al
    Adjunctive ultrasonography for breast cancer screening - Authors' reply.
    Lancet. 2016;387:2381-2.
    PubMed     Text format    


  20. AUTIER P, Boniol M
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380.
    PubMed     Text format    


  21. FUJITA T
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2380-1.
    PubMed     Text format    


  22. DALE A, Slade E, Heneghan C
    Adjunctive ultrasonography for breast cancer screening.
    Lancet. 2016;387:2379-80.
    PubMed     Text format    


    May 2016
  23. RUSSELL P, Floridis J
    Hypertrichosis lanuginosa acquisita: a rare dermatological disorder.
    Lancet. 2016;387:2035.
    PubMed     Text format    


  24. BERNSTEIN M
    Intraoperative radiation therapy for breast cancer: a patient's view.
    Lancet. 2016;387:1904-5.
    PubMed     Text format    


  25. GUILLEVIN L, Regent A
    Treating giant-cell arteritis: is IL-6 the cytokine to target?
    Lancet. 2016;387:1882-1883.
    PubMed     Text format    


    April 2016
  26. STRNAD V, Uter W, Polgar C
    Partial breast irradiation and the GEC-ESTRO trial - Authors' reply.
    Lancet. 2016;387:1718-9.
    PubMed     Text format    


  27. VICINI F, Shah C, Arthur D, Khan A, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717-8.
    PubMed     Text format    


  28. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Partial breast irradiation and the GEC-ESTRO trial.
    Lancet. 2016;387:1717.
    PubMed     Text format    


  29. KIRBY T
    Profile: Liverpool School of Tropical Medicine, UK.
    Lancet. 2016;387:1502.
    PubMed     Text format    


    March 2016
  30. MAIONE V, Stinco G, Errichetti E
    Multiple enchondromas and skin angiomas: Maffucci syndrome.
    Lancet. 2016 Mar 29. pii: S0140-6736(16)00088.
    PubMed     Text format    


  31. LAI FY, Groschel MI, van den Hende L, Diercks GF, et al
    Prolonged pyrexia and subtle skin lesions: polyarteritis nodosa.
    Lancet. 2016;387:1025-6.
    PubMed     Text format    


  32. JOHNSON P, Hoi A
    The art of managing medical uncertainty.
    Lancet. 2016;387:1026.
    PubMed     Text format    


  33. VILLIGER PM, Adler S, Kuchen S, Wermelinger F, et al
    Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Mar 4. pii: S0140-6736(16)00560.
    PubMed     Text format     Abstract available


    February 2016
  34. JOHNSTON SR
    Endocrine treatment for ductal carcinoma in situ: balancing risks and benefits.
    Lancet. 2016;387:819-21.
    PubMed     Text format    


    January 2016
  35. VICTORA CG, Bahl R, Barros AJ, Franca GV, et al
    Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect.
    Lancet. 2016;387:475-90.
    PubMed     Text format     Abstract available


  36. LAUX P, Tralau T, Tentschert J, Blume A, et al
    A medical-toxicological view of tattooing.
    Lancet. 2016;387:395-402.
    PubMed     Text format     Abstract available


  37. GRIFFITHS CE, Papp KA, Ball SG, Nickoloff BJ, et al
    Ixekizumab for psoriasis--Authors' reply.
    Lancet. 2016;387:226-7.
    PubMed     Text format    


  38. TSUDA K, Tanimoto T, Takenouchi S, Sakaue S, et al
    Ixekizumab for psoriasis.
    Lancet. 2016;387:225-6.
    PubMed     Text format    


  39. STRNAD V, Ott OJ, Hildebrandt G, Kauer-Dorner D, et al
    5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a
    Lancet. 2016;387:229-38.
    PubMed     Text format     Abstract available


  40. COLES CE, Yarnold JR
    Accelerated partial breast irradiation: the new standard?
    Lancet. 2016;387:201-2.
    PubMed     Text format    


    December 2015
  41. TCHERNEV G, Chokoeva AA
    Melanoma in a Chinese dragon tattoo.
    Lancet. 2015 Dec 23. pii: S0140-6736(15)01038.
    PubMed     Text format    


  42. GLADMAN DD
    Is it time for treat to target in psoriatic arthritis?
    Lancet. 2015;386:2450-2.
    PubMed     Text format    


  43. COATES LC, Moverley AR, McParland L, Brown S, et al
    Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.
    Lancet. 2015;386:2489-98.
    PubMed     Text format     Abstract available


  44. CAVALLI R, Milani GP, Chelleri C, Donelli S, et al
    Plaque-type glomuvenous malformations in a child.
    Lancet. 2015;386:e61.
    PubMed     Text format    


  45. FORBES JF, Sestak I, Howell A, Bonanni B, et al
    Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
    Lancet. 2015 Dec 11. pii: S0140-6736(15)01129.
    PubMed     Text format     Abstract available


  46. GANZ PA, Cecchini RS, Julian TB, Margolese RG, et al
    Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2015 Dec 10. pii: S0140-6736(15)01169.
    PubMed     Text format     Abstract available


  47. MARGOLESE RG, Cecchini RS, Julian TB, Ganz PA, et al
    Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2015 Dec 10. pii: S0140-6736(15)01168.
    PubMed     Text format     Abstract available


  48. MAERTENS JA, Raad II, Marr KA, Patterson TF, et al
    Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Lancet. 2015 Dec 9. pii: S0140-6736(15)01159.
    PubMed     Text format     Abstract available


    November 2015
  49. MIOSSEC P
    Progress in the treatment of juvenile dermatomyositis.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01023.
    PubMed     Text format    


  50. RUPERTO N, Pistorio A, Oliveira S, Zulian F, et al
    Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
    Lancet. 2015 Nov 27. pii: S0140-6736(15)01021.
    PubMed     Text format     Abstract available


  51. GNANT M
    Denosumab and fracture risk in women with breast cancer - Author's reply.
    Lancet. 2015;386:2057-8.
    PubMed     Text format    


  52. BOISSIEU PD, Trenque T
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2057.
    PubMed     Text format    


  53. FAROOKI A, Fornier M
    Denosumab and fracture risk in women with breast cancer.
    Lancet. 2015;386:2056-7.
    PubMed     Text format    


  54. THE LANCET
    HRT for menopause: a NICE treatment?
    Lancet. 2015;386:2030.
    PubMed     Text format    


  55. LOCKWOOD DN, Lambert SM, Walker SL
    Cutaneous nodules with positive autoantibodies: diagnostic pitfalls.
    Lancet. 2015;386:1916.
    PubMed     Text format    


  56. ZHANG G, Jin H, Chen H, Lu Q, et al
    Cutaneous nodules with positive autoantibodies: histoid leprosy.
    Lancet. 2015;386:1915-6.
    PubMed     Text format    


  57. OHUCHI N, Suzuki A, Sobue T, Kawai M, et al
    Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00774.
    PubMed     Text format     Abstract available


  58. YAFFE MJ, Jong RA
    Adjunctive ultrasonography in breast cancer screening.
    Lancet. 2015 Nov 4. pii: S0140-6736(15)00787.
    PubMed     Text format    


    October 2015
  59. DUDLEY RW, Smith C, Dishop M, Mirsky D, et al
    A cervical spine mass caused by Onchocerca lupi.
    Lancet. 2015;386:1372.
    PubMed     Text format    


    September 2015
  60. HELLIWELL P, Coates L
    Interleukin-17 inhibition in psoriatic arthritis.
    Lancet. 2015;386:1114-6.
    PubMed     Text format    


  61. MCINNES IB, Mease PJ, Kirkham B, Kavanaugh A, et al
    Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2015;386:1137-46.
    PubMed     Text format     Abstract available


  62. CAREY EJ, Ali AH, Lindor KD
    Primary biliary cirrhosis.
    Lancet. 2015 Sep 10. pii: S0140-6736(15)00154.
    PubMed     Text format     Abstract available


    July 2015

  63. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
    Lancet. 2015 Jul 23. pii: S0140-6736(15)61074.
    PubMed     Text format     Abstract available


  64. BRUFSKY A, Mathew A
    Bisphosphonates, bone, and breast cancer recurrence.
    Lancet. 2015 Jul 23. pii: S0140-6736(15)61163.
    PubMed     Text format    



  65. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
    Lancet. 2015 Jul 23. pii: S0140-6736(15)60908.
    PubMed     Text format     Abstract available


  66. MAYER EL, Burstein HJ
    Postmenopausal breast cancer: a best endocrine strategy?
    Lancet. 2015 Jul 23. pii: S0140-6736(15)61206.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: